Illumina (ILMN) | Stock Overview & Key Data
Illumina Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $540.63 on February 8, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Illumina
ILMN
|
19.18B Large-cap | 5.60% | 17.08% | 39.91% | 23.70% | 24.22% | 85.17% | -19.62% | -63.72% | 20.74% | 125.39% | 1,163.50% |
|
Thermo Fisher
TMO
|
174.55B Large-cap | 0.87% | 8.07% | 0.79% | -17.74% | -20.05% | 16.53% | -12.65% | -2.72% | 220.94% | 654.32% | 1,231.84% |
|
Danaher
DHR
|
126.39B Large-cap | -1.32% | 11.85% | -5.38% | -20.75% | -21.40% | -10.25% | -15.98% | -20.94% | 174.08% | 416.93% | 738.84% |
|
Idexx Laboratories
IDXX
|
44.66B Large-cap | 1.57% | 7.79% | -2.79% | -18.64% | -14.92% | 7.30% | 16.12% | -6.68% | 539.84% | 1,431.62% | 2,795.61% |
| 32.65B Large-cap | -2.11% | 3.78% | 7.87% | -3.22% | -4.70% | 10.90% | 7.19% | -10.46% | 186.24% | 282.67% | 444.17% | |
|
Waters
WAT
|
30.55B Large-cap | -1.54% | 8.67% | 23.36% | -7.18% | -6.34% | 3.87% | 32.07% | 3.74% | 165.28% | 286.07% | 736.74% |
Ownership & Short Interest
Calculate Your Illumina Investment Returns
Long-Term Investment Performance Analysis
Illumina stock price in Jul 2016 was $146.65, A $1,000.00 lump sum investment in Illumina made 9 years ago would be worth approximately $1,138.02 today, representing a positive return of 13.80%. This translates to an annualized return (CAGR) of 1.31%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ILMN's 52-week high and low?
- In the last 52 weeks, Illumina reached a high of $177.22 (on June 4, 2026) and a low of $86.03 (on June 16, 2025).
- What is the market cap and P/E ratio for ILMN?
- Curious about Illumina's size and valuation? Its market capitalization stands at 19.18B. When it comes to valuation, the P/E ratio (trailing twelve months) is 24.22, and the forward P/E (looking ahead) is 22.66.
- Does ILMN pay dividends? If so, what's the yield?
- As for dividends, Illumina isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Illumina's main competitors or similar companies to consider before investing?
When looking at Illumina, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO174.55B Healthcare Diagnostics & Research 16.53% -12.65% Danaher
DHR126.39B Healthcare Diagnostics & Research -10.25% -15.98% Idexx Laboratories
IDXX44.66B Healthcare Diagnostics & Research 7.30% 16.12% Agilent Technologies
A32.65B Healthcare Diagnostics & Research 10.90% 7.19% Waters
WAT30.55B Healthcare Diagnostics & Research 3.87% 32.07% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Illumina, Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Illumina's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 33.36%, the Debt to Equity ratio from the most recent quarter is 93.76, and its Gross Profit Margin stands at 65.49%.
- What is the recent revenue and earnings growth for ILMN?
- Looking at Illumina's growth, its revenue over the trailing twelve months (TTM) was $4B. Compared to the same quarter last year (YoY), quarterly revenue grew by 5.00%, and quarterly earnings saw a YoY growth of 78.60%.
- How much of ILMN stock is held by insiders and institutions?
- Wondering who owns Illumina stock? Company insiders (like executives and directors) hold about 0.22% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 108.01%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.